Global Patent Index - EP 0309100 A2

EP 0309100 A2 19890329 - Use of amylin or CGRP for the treatment of diabetes mellitus.

Title (en)

Use of amylin or CGRP for the treatment of diabetes mellitus.

Title (de)

Verwendung von Amylin oder CGRP zur Behandlung des Diabetes mellitus.

Title (fr)

Emploi de l'amyline ou CGRP pour le traitement du diabète sucré.

Publication

EP 0309100 A2 19890329 (EN)

Application

EP 88307927 A 19880826

Priority

GB 8720115 A 19870826

Abstract (en)

Amylin or amylin-NH2 or CGRP or a functional peptide fragment of amylin or amylin-NH2 or CGRP, or a conservative variant of the amylin or amylin-NH2 or CGRP or fragment, is provided as well as a soluble amylin or amylin-amide or active subfragment thereof or a lyophilized product for use in the treatment of diabetes mellitus or hypoglycaemia. Methods for preparation thereof are provided.

IPC 1-7

A61K 37/02; A61K 37/24; A61K 37/26

IPC 8 full level

A61K 38/23 (2006.01); A61K 38/22 (2006.01); A61K 38/27 (2006.01); A61K 38/28 (2006.01); A61K 45/00 (2006.01); A61P 3/08 (2006.01); A61P 3/10 (2006.01); C07K 14/575 (2006.01); A61K 38/00 (2006.01)

CPC (source: EP US)

A61K 33/30 (2013.01 - EP US); A61K 38/225 (2013.01 - EP US); A61K 38/28 (2013.01 - EP US); A61P 3/08 (2018.01 - EP); A61P 3/10 (2018.01 - EP); A61P 5/48 (2018.01 - EP); C07K 14/575 (2013.01 - EP US); A61K 38/00 (2013.01 - EP US)

C-Set (source: EP US)

  1. A61K 38/225 + A61K 2300/00
  2. A61K 33/30 + A61K 2300/00
  3. A61K 38/28 + A61K 2300/00

Citation (applicant)

  • EP 0289287 A2 19881102 - AMYLIN CORP [US]
  • CLARK A..; COOPER G.J.S. ET AL., LANCET, 2 August 1987 (1987-08-02)
  • COOPER ET AL.: "Purification and Characterization of a Peptide from Amyloid-Rich Pancreases of Type 2 Diabetic Patients", PROC. NATL. ACAD. SCI. USA, vol. 84, 1987
  • P. WESTERMARK ET AL., PROC. NATL. ACAD. SCI. USA, vol. 84, June 1987 (1987-06-01), pages 3881 - 3885
  • M.O. DAYHOFF: "Atlas of Protein Sequence and Structure", vol. 5, NATIONAL BIOMEDICAL RESEARCH FOUNDATI, article "A Model of Evolutionary Change in Proteins", pages: 345 - 352
  • COOPER ET AL., LANCET, vol. 2, 1987, pages 964
  • M.O. DAYHOFF: "Atlas of Protein Sequence and Structure", vol. 5, 1978, NATIONAL BIOMEDICAL RESEARCH FOUNDATION, article "A Model of Evolutionary Change in Proteins", pages: 345 - 352
  • COOPER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 84, 1987, pages 8628 - 8623
  • COOPER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 84, 1987, pages 8628 - 8623
  • LARNER, J. ET AL.: "The Pharmacologic Basis of Therapeutics", 1985, MACMILLAN, article "Insulin and Oral Hypogylcaemic Drugs; Glucagon.", pages: 1501 - 02
  • HAGEDORN ET AL.: "Protamine Insulinate", JAMA, vol. 106, 1936, pages 177 - 180

Designated contracting state (EPC)

AT BE CH DE ES FR GB GR IT LI LU NL SE

DOCDB simple family (publication)

EP 0309100 A2 19890329; EP 0309100 A3 19910403; EP 0309100 B1 19970723; AT E155688 T1 19970815; AU 2157588 A 19890720; AU 634954 B2 19930311; CA 1341060 C 20000725; DE 3855970 D1 19970904; DE 3855970 T2 19980129; DK 473888 A 19890405; DK 473888 D0 19880825; EP 0787741 A1 19970806; ES 2106721 T3 19971116; FI 883936 A0 19880825; FI 883936 A 19890227; GB 8720115 D0 19870930; GR 3024705 T3 19971231; HK 1000934 A1 19980508; JP 2828250 B2 19981125; JP H0196137 A 19890414; NO 883828 D0 19880826; NO 883828 L 19890227; SG 93776 A1 20030121; US 5124314 A 19920623; US 5641744 A 19970624

DOCDB simple family (application)

EP 88307927 A 19880826; AT 88307927 T 19880826; AU 2157588 A 19880826; CA 575792 A 19880826; DE 3855970 T 19880826; DK 473888 A 19880825; EP 96119980 A 19880826; ES 88307927 T 19880826; FI 883936 A 19880825; GB 8720115 A 19870826; GR 970402349 T 19970911; HK 97102456 A 19971216; JP 21233288 A 19880826; NO 883828 A 19880826; SG 1996003410 A 19880826; US 34134294 A 19941117; US 71503191 A 19910610